The Baby Makers: Critics Push for Regulation of India's Booming Surrogacy Industry
By ABC,
ABC
| 04. 15. 2014
As more than 800 million Indians go to the polls this month, the main political party candidates are being urged to finally push through legislation to regulate the country's booming commercial surrogacy industry.
The calls come as increasing numbers of foreigners, including many Australians, pay thousands of dollars to Indian surrogacy centres to fulfil their need to have children.
The industry has been criticised for operating in a regulatory vacuum, and while there are some rules for people who take the journey to India, it is still a minefield for many unsuspecting parents.
Author and critic Kishwar Desai has strong reservations about the lack of legal oversight and what it means for the women who rent out their wombs.
"We're treating these women like animals, like you would do with cattle ... so I think that is something we need to be very careful about," she said.
"It's not the numbers of the women who die - and indeed we may not even know about them because a lot of the clinics are operating without any regulation, without any rules...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...